posteditor

posteditor

Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA

P Prescription Drug User Fee Act (PDUFA) date set for August 25, 2026 For U.S. media and investors only DUBLIN, April 27, 2026 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) accepted…

Conscientia Health Launches Virtual Primary Care Services – A Groundbreaking Breakthrough in AI-Powered Integrative Telehealth Uniting Mental and Physical Health For Whole Person Care Under One Virtual Roof.

B Conscientia Health Delivers Coordinated Whole-Person Care to 15,000+ Existing Mental Health Patients Across 73 Locations in 50 States and 20 Local NJ Sites. NEW YORK, April 27, 2026 /PRNewswire/ — Conscientia Health, the rapidly scaling, clinician led leader in mental…